Sign in
4

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0001470831-26-000009

Director acquired 5,958 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Anderson Kenneth Carl · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-01-02 Grant or award : show line 1 in the form +5,958 $1.93 $11,499 146,532 D
Loading xslF345X05/wk-form4_1767647442.xml…